Many studies have focused on the role of arginine vasopressin (AVP ... (i.c.v.) injections of antagonists to the AVP-V1a receptor (AVPR) or of antagonists to the OXT receptor (OXTR) reduced ...

Researchers from Gedeon Richter plc have reported the discovery of novel dual vasopressin V1A/V2 antagonist drug candidates for the potential treatment of hyponatremia.